Atlanta Capital Management’s Core Laboratories CLB Stock Holding History

Atlanta Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-278,296	Closed	-$31.7M	–	187
2015 Q2	$31.7M	Sell	278,296 -42,630	-13%	-$5.17M	0.22%	117
2015 Q1	$33.5M	Buy	320,926 +58,929	+22%	+$6.28M	0.23%	118
2014 Q4	$31.5M	Buy	261,997 +188,189	+255%	+$24.7M	0.22%	116
2014 Q3	$10.8M	Buy	73,808 +38,475	+109%	+$5.94M	0.08%	161
2014 Q2	$5.9M	Buy	35,333 +31,903	+930%	+$5.68M	0.04%	169
2014 Q1	$681K	Hold	3,430	–	–	﹤0.01%	189
2013 Q4	$655K	Sell	3,430 -478	-12%	-$89K	﹤0.01%	184
2013 Q3	$661K	Sell	3,908 -866	-18%	-$134K	﹤0.01%	183
2013 Q2	$724K	Buy	+4,774	New	+$676K	0.01%	177

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Atlanta Capital Management's CLB Position: Q3 2015 in Review

Atlanta Capital Management sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 278,296 shares — an estimated $31.7M sold.

Atlanta Capital Management first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $33.5M in Q1 2015. 352 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

Atlanta Capital Management reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
Atlanta Capital Management sold 278,296 Core Laboratories shares in Q3 2015, an estimated $31.7M.
Atlanta Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
Atlanta Capital Management's Core Laboratories position peaked at $33.5M in Q1 2015.
352 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Atlanta Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.